| Dr Alain Coppel, MD | |
|
2809 W Charleston Blvd, Suite 150, Las Vegas, NV 89102-1998 | |
| (702) 476-9999 | |
| (702) 946-1343 |
| Full Name | Dr Alain Coppel |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 23 Years |
| Location | 2809 W Charleston Blvd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316057573 | NPI | - | NPPES |
| 100510943 | Medicaid | NV |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coppel Medical Enterprise Llc | 8921140641 | 17 |
News Archive
Duke University's MURDOCK Study, the Duke Clinical Research Institute and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with chronic obstructive pulmonary disease (COPD).
The health bills pending in Congress may end the practice of insurance rates based on gender and denials based on a history of domestic abuse.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
Most countries are not fulfilling their international legal obligations during COVID-19 and other public health emergencies, reveals new research by a consortium of 13 leading global health law scholars, hosted by the Global Strategy Lab (GSL) at York University.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
› Verified 8 days ago
| Entity Name | Coppel Medical Enterprise Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184957268 PECOS PAC ID: 8921140641 Enrollment ID: O20100119000422 |
News Archive
Duke University's MURDOCK Study, the Duke Clinical Research Institute and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with chronic obstructive pulmonary disease (COPD).
The health bills pending in Congress may end the practice of insurance rates based on gender and denials based on a history of domestic abuse.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
Most countries are not fulfilling their international legal obligations during COVID-19 and other public health emergencies, reveals new research by a consortium of 13 leading global health law scholars, hosted by the Global Strategy Lab (GSL) at York University.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alain Coppel, MD 2809 W Charleston Blvd, Suite 150, Las Vegas, NV 89102-1998 Ph: (702) 476-9999 | Dr Alain Coppel, MD 2809 W Charleston Blvd, Suite 150, Las Vegas, NV 89102-1998 Ph: (702) 476-9999 |
News Archive
Duke University's MURDOCK Study, the Duke Clinical Research Institute and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with chronic obstructive pulmonary disease (COPD).
The health bills pending in Congress may end the practice of insurance rates based on gender and denials based on a history of domestic abuse.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
Most countries are not fulfilling their international legal obligations during COVID-19 and other public health emergencies, reveals new research by a consortium of 13 leading global health law scholars, hosted by the Global Strategy Lab (GSL) at York University.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
› Verified 8 days ago
Mark Livingston, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9127 W Russell Rd Ste 110, Las Vegas, NV 89148 Phone: 702-878-0070 Fax: 702-209-2064 | |
Dr. Charles Minh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 205 Elder View Dr, Las Vegas, NV 89138 Phone: 702-907-6464 | |
Ryan Nimer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-209-2064 | |
Liam Kelly Sullivan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 | |
James Murphy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2635 Box Canyon Dr, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Scott Young, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7250 Peak Dr Ste 100, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Dr. Derek Michael Goffstein, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 |